The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chernevskaya E.A.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Zozulya S.A.

Mental Health Research Center

Beloborodova N.V.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Klyushnik T.P.

Mental Health Research Center

Buyakova I.V.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

The association of aromatic microbial metabolites, inflammatory and autoimmune biomarkers with clinical dynamics in severe diseases of the central nervous system

Authors:

Chernevskaya E.A., Zozulya S.A., Beloborodova N.V., Klyushnik T.P., Buyakova I.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7): 78‑85

DOI: 10.17116/jnevro202012007178

Views: 1948

Downloaded: 44

Download PDF (RU)
Contact the author
Table of contents

THE ASSOCIATION OF AROMATIC MICROBIAL METABOLITES, INFLAMMATORY AND AUTOIMMUNE BIOMARKERS WITH CLINICAL DYNAMICS IN SEVERE DISEASES OF THE CENTRAL NERVOUS SYSTEM
THE ASSOCIATION OF AROMATIC MICROBIAL METABOLITES, INFLAMMATORY AND AUTOIMMUNE BIOMARKERS WITH CLINICAL DYNAMICS IN SEVERE DISEASES OF THE CENTRAL NERVOUS SYSTEM

To cite this article:

Chernevskaya EA, Zozulya SA, Beloborodova NV, Klyushnik TP, Buyakova IV. The association of aromatic microbial metabolites, inflammatory and autoimmune biomarkers with clinical dynamics in severe diseases of the central nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7):78‑85. (In Russ.)
https://doi.org/10.17116/jnevro202012007178

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
 
МСФ на ЯМ
Close metadata

OBJECTIVE

To identify the association between the changes in the profile of microbial metabolites, inflammatory and autoimmune markers and the dynamics of neurological status in chronic critically ill patients with diseases of the central nervous system (CNS).

MATERIAL AND METHODS

Sixty serum samples from 37 patients, aged 19—77 years, with severe CNS diseases were studied. The changes in clinical condition were assessed with NIHSS, the Rankin scale, the Glasgow Coma Scale, the FOUR Coma Scale and the Rivermead Mobility Index. The levels of aromatic microbial metabolites (AMM) and several inflammatory and autoimmune biomarkers, including the contents of procalcitonin (PCT) and S100, the activity of leukocyte elastase (LE) and a1-proteinase inhibitor a1-PI, the levels of autoantibodies to S100b and MBP were measured. Serum from 60 age- and sex-matched healthy people with no signs of neurological and somatic pathology was used as a control.

RESULTS

All patients were divided into groups depending on the neurological dynamics: A — positive (n=16), B — without dynamics (n=15), C — negative (n=6). The study revealed a profile of AMM, as well as inflammatory and autoimmune biomarkers associated with the severity of neurological disorders. A significant increase in acute phase proteins, S-100 level and a decrease in the functional activity of neutrophils (via LE activity) were observed in the serum of patients. The different dynamics of neurological status was associated with the multidirectional changes in the microbial metabolites profile and biomarkers. The correlations between the clinical and biological parameters indicate that AMM might modulate immune reactions in patients with different dynamics of neurological status.

CONCLUSION

The results suggest the involvement of AMM and the level of immune activation via biomarkers in the pathogenesis of neurological dysfunction. Dynamic changes in the profile of microbial metabolites and the level of activation of the immune system may be a promising tool for prediction of neurological recovery.

Keywords:

aromatic microbial metabolites
inflammatory and autoimmune biomarkers
severe diseases of the central nervous system

Authors:

Chernevskaya E.A.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Zozulya S.A.

Mental Health Research Center

Beloborodova N.V.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Klyushnik T.P.

Mental Health Research Center

Buyakova I.V.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology

Received:

04.10.2019

Accepted:

16.03.2020

List of references:

  1. Nelson JE, Cox CE, Hope AA, Carson SS. Chronic critical illness. Am J Respir Crit Care Med. 2010;182(4):446-454.  https://doi.org/10.1164/rccm.201002-0210CI
  2. Parfenov AL, Petrova MV, Solovyova NN, Stepanyuk TA, Zachepilova KO, Saidov ShKh, Grechko AV. Protein-energy insufficiency and lethality structure in patients in chronic critical condition. Health and Education Millennium. 2018;20:8:55-60. (In Russ.). https://doi.org/10.26787/nydha-2226-7425-2018-20-8
  3. Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases. Neurotherapeutics. 2016;13(4):685-701.  https://doi.org/10.1007/s13311-016-0477-8
  4. Deczkowska A, Amit I, Schwartz M. Microglial immune checkpoint mechanisms. Nat Neurosci. 2018;21(6):779-786.  https://doi.org/10.1038/s41593-018-0145-x
  5. Cryan JF, O’Riordan KJ, Cowan CS, Kiran V KV, Bastiaanssen TF, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte LM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O’Connor O, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, and Dinan TG. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99:1877-2013. https://doi.org/10.1152/physrev.00018.2018
  6. Liu P, Peng G, Zhang N, Baohong Wang B, Benyan Luo B. Crosstalk between the gut microbiota and the brain: an update on neuroimaging findings Front. Neurol. 2019. Aug 13;10:883  https://doi.org/10.3389/fneur.2019.00883
  7. Dovrolis N, Kolios G, Spyrou GM, Maroulakou I. Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders. Brief Bioinform. 2017;21:20(3):825-841.  https://doi.org/10.1093/bib/bbx154
  8. Cenit MC, Sanz Y, Codoñer-Franch P. Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol. 2017;14:23(30):5486-5498. https://doi.org/10.3748/wjg.v23.i30.5486
  9. Kirpichenko AA, Kim IY. Psychobiotics: can gut microbiota influence host’s mental health? Vestnik VGMU. 2017;16(2):26-42. (In Russ.). https://doi.org/10.22263/2312-4156.2017.2.26
  10. Beloborodova NV, Ostrova IV. Sepsis-associated encephalopathy. General Reanimatology. 2017;6(13):121-135. (In Russ.).
  11. Beloborodova NV, Sarshor YN, Bedova AY, Chernevskaya EA, Pautova AK. Involvement of Aromatic Metabolites in the Pathogenesis of Septic Shock. Shock. 2018;50(3):273-279.  https://doi.org/10.1097/SHK.0000000000001064
  12. Beloborodova NV. Sepsis. Metabolomic approach. M.: MIA; 2018. (In Russ.).
  13. Chernevskaya EA, Beloborodova NV. Gut Microbiome in Critical Illness (Review). General Reanimatology. 2008;14(5):96-119. (In Russ.). https://doi.org/10.15360/1813-9779-2018-5-96-119
  14. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8):1221-1238. https://doi.org/10.1210/me.2014-1108
  15. Jeremias IC, Victorino VJ, Machado JL, Barroso WA, Ariga SK, Lima TM, Soriano FG. The severity of cecal ligature and puncture-induced sepsis correlates with the degree of encephalopathy, but the sepsis does not lead to acute activation of spleen lymphocytes in mice. Mol Neurobiol. 2016;53(5):3389-3399. https://doi.org/10.1007/s12035-015-9290-3
  16. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S. The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine. 2014;6(263):263ra158. https://doi.org/10.1126/scitranslmed.3009759
  17. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108:16050-16055. https://doi.org/10.1073/pnas.1102999108
  18. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36:305-312.  https://doi.org/10.1016/j.tins.2013.01.005
  19. Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience. 2017;20(2):145-156.  https://doi.org/10.1038/nn.4476
  20. Zozulya SA, Oleichik IV, Androsova LV, Otman IN, Sarmanova ZV, Stolyarov SA, Bizyaeva AS, Yunilainen OA, Klyushnik TP. Monitoring trend of endogenous psychoses by immunological parameters. Psikhicheskoe Zdorov’e. 2017;1:11-18. (In Russ.).
  21. Klyushnik TP, Androsova LV, Zozulya SA, Otman IN, Vetlugina TP, Nikitina VB. Comparative analysis of inflammatory markers in endogenous and non-psychotic mental disorders. Sibirskij Vestnik Psihiatrii i Narkologii. 2018;2(99):64-69. (In Russ.). https://doi.org/10.26617/1810-3111-2018-2(99)-64-69
  22. Dotsenko VL, Neshkova EA, Yarovaya GA. Detection of human leukocyte elastase from a complex with a plasma α1-proteinase inhibitor by its enzymatic activity with a synthetic substrate. Voprosy Meditsinskoi Khimii. 1994;40(3):20-25. (In Russ.).
  23. Nartikova VF, Paskhina TS. Unified method for determining the activity of alpha-1-antitrypsin and alpha-2-macroglobulin in human serum (plasma). Voprosy Meditsinskoi Khimii. 1979;25:4:494-499. (In Russ.).
  24. Klyushnik TP, Lideman RR, Danilovskaya EV. Autoantibodies to the nerve growth factor in pathology of the development of the nervous system. Rossiyskiy Vestnik Perinatologii. i Pediatrii. 1997;3:36-40. (In Russ.).
  25. Beloborodova NV, Osipov AA, Bedova AYu. Biological properties of some low molecular weight aromatic microbial metabolites associated with sepsis. Antibiotics and Chemotherapy. 2013;58(7-8):48-61. (In Russ.).
  26. Beloborodova NV, Bayramov IT, Olenin AYu, Fedotcheva NI. Exometabolites of some anaerobic microorganisms of human microflora. M.: Biomedical chemistry; 2011. (In Russ.).
  27. Yao B, Zhang LN, Ai YH, Liu ZY, Huang L. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res. 2014;39(7):1263-1269. https://doi.org/10.1007/s11064-014-1308-0
  28. Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, Donato R. S100B Expression in and effects on microglia. Glia. 2001;33(2):131-142. 
  29. Hedtjärn M, Mallard C, Hagberg H Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 2004;24(12):1333-1351.
  30. Chekhonin VP, Dmitriyeva TB, Zhirkov YuA. Immunochemical analysis of neurospecific antigens. M.: Meditsina; 1999. (In Russ.).
  31. Kliushnik TP, Zozulya SA, Androsova LV, Sarmanova ZV, Otman IN, Dupin AM, Panteleeva GP, Oleichik IV, Abramova LI, Stolyarov SA, Shypilova ES, Borisova OA. Immunological monitoring of endogenous attack-like psychoses. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(2):37-41. (In Russ.).
  32. Otman IN, Zozulya SA, Chukanova AS, Nadareishvili GG, Simonov AN, Gusev EI, Klyushnik TP. Immunological predictors of acute post-stroke period. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(8):39-45. (In Russ.). https://doi.org/10.17116/jnevro201911908239
  33. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. Journal of Neuroinflammation. 2013;10:43:1-24.  https://doi.org/10.1186/1742-2094-10-43
  34. Robinson-Agramonte MLA, Gonçalves CA, Farina de Almeida R, González Quevedo A, Chow S, Velázquez Pérez L, Díaz de la Fé A, Sesterheim P, Souza DOG Neuroinflammation and Neuromodulation in Neurological Diseases. Behav Sci (Basel). 2019;12:9(9). pii: E99.  https://doi.org/10.3390/bs9090099
  35. Piskunov AK. Neuroinflammation biomarkers. Neyrokhimiya. 2010;27(1):67-73. (In Russ.).

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.